BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37431249)

  • 1. Endometrial carcinoma in patients under 40 years of age: insights from the Bulgarian Cancer Registry.
    Yordanov A; Kostov S; Kornovski Y; Slavchev S; Ivanova Y; Calleja-Agius J; Di Fiore R; Suleiman S; Piciu A; Hasan I; Vasileva-Slaveva M
    Ginekol Pol; 2023; 94(4):275-282. PubMed ID: 37431249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The assessment of overall survival (OS) after adjuvant chemotherapy for patients with malignant endometrial cancer in Poland.
    Teter Z; Śliwczyński A; Brzozowska M; Świerkowski M; Jacyna A; Pinkas J; Sierocka A; Marczak M; Dańska-Bidzińska A; Bidziński M; Wierzba W
    Ginekol Pol; 2017; 88(6):296-301. PubMed ID: 28727127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosquamous Carcinoma of the Uterine Cervix - Impact of Histology on Clinical Management.
    Yordanov A; Kostov S; Slavchev S; Strashilov S; Konsoulova A; Calleja-Agius J; Di Fiore R; Suleiman S; Kubelac P; Vlad C; Achimas-Cadariu P; Vasileva-Slaveva M
    Cancer Manag Res; 2021; 13():4979-4986. PubMed ID: 34188551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peri-operative and survival outcomes analysis of patients with endometrial cancer managed by three surgical approaches: a long-term Bulgarian experience.
    Tomov ST; Gorchev GA; Kiprova DK; Lyubenov AD; Hinkova NH; Tomova VD; Gorcheva ZV; Ahmad S
    J Robot Surg; 2022 Dec; 16(6):1367-1382. PubMed ID: 35142980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes.
    Gadducci A; Multinu F; De Vitis LA; Cosio S; Carinelli S; Aletti GD
    Gynecol Oncol; 2023 Apr; 171():95-105. PubMed ID: 36842409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
    Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased survival in non-endometrioid endometrial cancer after introducing lymphadenectomy and tailoring radiotherapy - A population-based cohort study.
    Åkesson Å; Adok C; Dahm-Kähler P
    Eur J Cancer; 2022 Jul; 169():54-63. PubMed ID: 35500461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
    Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis.
    Chambers LM; Jia X; Rose PG; AlHilli M
    Gynecol Oncol; 2021 Feb; 160(2):405-412. PubMed ID: 33221023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial cancer in young women: prognostic factors and treatment outcomes in women aged ≤40 years.
    Son J; Carr C; Yao M; Radeva M; Priyadarshini A; Marquard J; Michener CM; AlHilli M
    Int J Gynecol Cancer; 2020 May; 30(5):631-639. PubMed ID: 32213530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and clinical management of endometrial carcinoma in the Republic of Georgia in the last 30 years.
    Charkviani T; Charkviani L; Chitiashvili R; Glonti L
    Eur J Gynaecol Oncol; 1996; 17(4):292-5. PubMed ID: 8856309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
    Farrell R; Dixon SC; Carter J; Webb PM
    Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sociodemographic disparities in stage-specific incidences of endometrial cancer: a registry-based study in West Sweden, 1995-2016.
    Svanvik T; Marcickiewicz J; Sundfeldt K; Holmberg E; Strömberg U
    Acta Oncol; 2019 Jun; 58(6):845-851. PubMed ID: 30849264
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
    He Y; Wang Y; Ji C; Liu Y; Wu YM
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
    [No Abstract]   [Full Text] [Related]  

  • 17. First-stage clear-cell endometrial carcinoma with paraaortic lymph node recurrence: a case report.
    Strashilov SA; Slavchev S; Kostov S; Yordanov A
    Prz Menopauzalny; 2021 Apr; 20(1):57-60. PubMed ID: 33935622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
    Cuenca RE; Giachino J; Arredondo MA; Hempling R; Edge SB
    Cancer; 1996 May; 77(10):2058-63. PubMed ID: 8640670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
    Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
    Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.
    AlHilli MM; Mariani A; Bakkum-Gamez JN; Dowdy SC; Weaver AL; Peethambaram PP; Keeney GL; Cliby WA; Podratz KC
    Gynecol Oncol; 2014 Jun; 133(3):485-93. PubMed ID: 24690476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.